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Abstract: Retinal hypoxia is the potentially blinding mechanism underlying a number of 
sight-threatening disorders including central retinal artery occlusion, ischemic central retinal 
vein thrombosis, complications of diabetic eye disease and some types of glaucoma. Hypoxia 
is implicated in loss of retinal ganglion cells (RGCs) occurring in such conditions. RGC death 
occurs by apoptosis or necrosis. Hypoxia-ischemia induces the expression of hypoxia inducible 
factor-1α and its target genes such as vascular endothelial growth factor (VEGF) and nitric 
oxide synthase (NOS). Increased production of VEGF results in disruption of the blood retinal 
barrier leading to retinal edema. Enhanced expression of NOS results in increased production 
of nitric oxide which may be toxic to the cells resulting in their death. Excess glutamate release 
in hypoxic-ischemic conditions causes excitotoxic damage to the RGCs through activation of 
ionotropic and metabotropic glutamate receptors. Activation of glutamate receptors is thought to 
initiate damage in the retina by a cascade of biochemical effects such as neuronal NOS activation 
and increase in intracellular Ca2+ which has been described as a major contributing factor to RGC 
loss. Excess production of proinﬂ  ammatory cytokines also mediates cell damage. Besides the 
above, free-radicals generated in hypoxic-ischemic conditions result in RGC loss because of an 
imbalance between antioxidant- and oxidant-generating systems. Although many advances have 
been made in understanding the mediators and mechanisms of injury, strategies to improve the 
damage are lacking. Measures to prevent neuronal injury have to be developed.
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Introduction
The structural and functional integrity of the retina depends on a regular oxygen sup-
ply. Being one of the most metabolically active tissues, retina consumes oxygen more 
rapidly than other tissues (Cohen and Noell 1965) such as the brain (Anderson and 
Saltzman 1964; Ames 1992). The presence of a dual circulation (Osborne et al 2004) 
makes retinal oxygenation unique. The photoreceptors and the greater portion of the 
outer plexiform layer receive nourishment from the choriocapillaris indirectly whereas 
the inner retinal layers are supplied by the superﬁ  cial and deep capillary plexuses 
formed by branches of the central artery of the retina. Inner layers of the retina are 
known to show highest sensitivity to hypoxic challenges (Janáky et al 2007), whereas 
the outer retina is more resistant to a hypoxic stress (Tinjust et al 2002).
Retinal hypoxia occurs in ocular conditions such as central retinal artery occlu-
sion and ischemic central retinal vein thrombosis. Hypoxia is also implicated in the 
development of glaucoma (Flammer 1994; Tielsch et al 1995; Chung et al 1999; Osborne 
et al 1999b; Costa et al 2003; Tezel and Wax 2004), diabetes (Linsenmeier et al 1998), 
and is thought to underlie many of the sight-threatening complications of diabetic eye 
disease including retinal and optic nerve head neovascularization. Systemic causes 
of retinal hypoxia include the cardiovascular effects of chronic obstructive airways 
disease, the ocular ischemic syndrome associated with arterial obstructive condi-
tions such as carotid artery stenosis (Brown and Magargal 1988) and Takayasu’s 
arteritis (Shelhamer et al 1985), hyperviscosity syndromes (Ashton et al 1963) or 
following trauma (Purtscher’s retinopathy; Purtscher 1912; Buckley and James 1997). Clinical Ophthalmology 2008:2(4) 880
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Retinal hypoxia associated with the above conditions is a 
common cause of visual impairment and blindness (Osborne 
et al 2004). Retinal ganglion cells (RGCs) have been reported 
to be particularly sensitive to acute, transient, and mild 
systemic hypoxic stress (Kergoat et al 2006). Loss of RGCs 
occurs in many ophthalmic conditions such as glaucoma 
and diabetes (Sucher et al 1997; Abu-El-Asrar et al 2004), 
hypoxia being implicated in such a loss (Wax and Tezel 
2002; Tezel and Wax 2004; Chen et al 2007). This review 
details some of the molecular and cellular mechanisms which 
may be involved in RGC death in ocular conditions associ-
ated with hypoxia-ischemia. A better understanding of the 
mechanisms causing hypoxic damage to RGCs may aid the 
development of therapies aimed at reducing blindness from 
retinal hypoxic-ischemic visual loss.
A number of systemic and cellular responses such as gly-
colysis, angiogenesis, vasodilation, and erythropoiesis enable 
the organisms to respond to hypoxia (Harris 2002). The neu-
ral tissue is capable of inducing protective mechanisms under 
hypoxic-ischemic conditions (Kitagawa et al 1990) which are 
induced within minutes and are of putative importance for 
limiting the damage. However, these protective mechanisms 
are lost within hours of the hypoxic-ischemic insult (Prass 
et al 2003) following which cell death and tissue damage 
occur. Transcriptional activator hypoxia-inducible factor-1α 
(HIF-1α) is a master regulator of cellular O2 homeostasis 
(Iyer et al 1998). Hypoxia is known to induce HIF-1α and 
its target genes (Bernaudin et al 2002) such as vascular 
endothelial growth factor (VEGF) and nitric oxide synthase 
(NOS) in many tissues. Overproduction of these factors has 
been implicated in neuronal death in hypoxic-ischemic con-
ditions. In addition, enhanced extracellular accumulation of 
glutamate and inﬂ  ammatory cytokines damage the neurons. 
Upregulated expression of HIF-1α, VEGF, and various 
isoforms of NOS has been reported in the retina following 
hypoxic injury (Kaur et al 2006) and in the glaucomatous 
retina (Tezel and Wax 2004).
Retinal ganglion cell death 
in hypoxia ischemia
RGC death has been reported to occur in many experimental 
studies using different methods to induce retinal ischemia 
(Adachi et al 1996; Goto et al 2002; Lafuente et al 2002; 
Wang et al 2002; Chidlow and Osborne 2003). Neuronal 
degeneration resulting from retinal hypoxia-ischemia, caused 
by oxygen and substrate deprivation, may be mediated by 
free oxygen radicals (Block and Schwarz 1997; Muller 
et al 1997; Szabo et al 1997), glutamate excitotoxicity 
(Louzada-Junior et al 1992; Osborne et al 2004; Kaur et al 
2006), inﬂ  ammation (Hayashi et al 1996) as well as disrup-
tion of the blood retinal barrier (Kuroiwa et al 1985; Kaur 
et al 2007).
Based on morphological, histochemical, and biochemical 
criteria, cell death has been classified as apoptotic 
or necrotic in hypoxic-ischemic conditions (Mehmet et al 
1994; Charriaut-Marlangue et al 1996a, 1996b; Chopp and 
Li 1996; Macaya 1996; Yue et al 1997; MacManus and 
Linnik 1997; Banasiak and Haddad 1998; Pulera et al 1998; 
Renolleau et al 1998; Nakajima et al 2000). In necrotic death, 
swelling of cell body, disruption of plasma membrane, and 
irregularly scattered condensation of nuclear chromatin 
occur (Dessi et al 1993; Gwag et al 1997; Sohn et al 1998). 
In apoptosis, on the other hand, nuclear condensation and 
contraction occurs early with the membrane and organelles 
remaining intact until the ﬁ  nal stages. Similar necrotic (Buchi 
1992; Joo et al 1999) and apoptotic changes in RGCs have 
been observed in experimental hypoxic-ischemic conditions 
(Buchi 1992; Joo et al 1996, 1999) as well as in elevated intra-
ocular pressure (Garcia-Valenzuela et al 1995; Quigley et al 
1995) and glaucoma (Kerrigan et al 1996) where ischemia is 
involved in retinal damage directly or indirectly.
Ischemia is known to induce several apoptosis-regulatory 
genes in cells. Upregulated expression of  Bax, a bcl-2 homo-
log that effects apoptosis in neurons destined to die, after 
global ischemia (Krajewski et al 1995; Chen et al 1996) and 
expression of antiapoptotic gene bcl-2 in neurons that survive 
ischemia (Shimazaki et al 1994; Chen et al 1997) has been 
reported suggesting that endogenously induced apoptosis-
regulatory genes may play a role in determining the fate of 
ischemic neurons. Caspases play a key role in cell death by 
apoptosis (Jacobson and Evan 1994). Among the caspases, 
caspase-3 is activated by many cell death signals and cleaves 
a variety of important cellular proteins (Jänicke et al 1998; 
Namura et al 1998). Caspase-3-like protease activation is 
likely to be relevant in neuronal apoptosis in ischemic injury 
(Fink et al 1998; Namura et al 1998). Caspase-2 and -3 
(Kurokawa et al 1999; Lam et al 1999) and Bax (Kaneda 
et al 1999) have been reported to be involved in retinal cell 
loss after ischemic insult.
Hypoxia-ischemia, retinal edema, 
and vascular endothelial growth 
factor
Hypoxia-ischemia underlies various blinding ocular condi-
tions such as diabetic retinopathy and may play a role in the 
wet form of age-related macular degeneration and in the visual Clinical Ophthalmology 2008:2(4) 881
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loss from retinal detachment (Tso 1982; Yanoff et al 1984; 
Marmor 1999; Bressler et al 2001; Davis and Blodi 2001; 
Jackson et al 2003). It is associated with ﬂ  uid accumulation 
in the extracellular spaces (vasogenic edema) or intracellulary 
(cytotoxic edema) in the neural retina (Yanoff et al 1984; 
Marmor 1999). The extracellular spaces in the inner retina 
consist of the narrow clefts between the tightly packed cellu-
lar elements (Hamann 2002). Fluid leaking out from damaged 
capillaries in the inner retina accumulates in the extracellular 
spaces displacing the retinal cellular elements and disrupting 
the normal anatomy of the neuronal connections (Hamann 
and La Cour 2005). Factors implicated in pathogenesis of 
macular edema are retinal ischemia, oxidative stress, and 
inﬂ  ammation (Bresnick 1983; Guex-Crosier 1999; van Dam 
2002; Miyake and Ibaraki 2002). Increased permeability of 
blood-retinal barrier (BRB) resulting in ﬂ  uid accumulation 
has been reported to contribute to retinal neuronal degen-
eration by compression (Cunha-Vaz and Travassos 1984; 
Antcliff and Marshall 1999; Marmor 1999; Reichenbach et al 
2007). Excess production of VEGF, nitric oxide (NO) and 
aquaporin-4 in hypoxic-ischemic insults causes dysfunction 
of the BRB in the inner retina resulting in serum leakage 
into the retinal tissues (Marmor 1999; Kaur et al 2007) and 
retinal edema (Hamann and La Cour 2005). In addition to 
an increase in vascular permeability, hypoxia has also been 
correlated with endothelial cell death, leukocyte plugging of 
vessels, and microaneurysms (Linsenmeier et al 1998).
VEGF, also known as vascular permeability factor 
(Senger et al 1983), is a key player of angiogenesis in health 
and disease (Ferrara 2001; Carmeliet 2003). VEGF binds to 
two tyrosine kinase receptors, VEGFR-1 or fms-like tyrosine 
kinase Flt-1 and VEGFR-2 or fetal liver kinase receptor Flk-1 
to exert its actions (De Vries et al 1992; Quinn et al 1993; 
Neufeld et al 1999; Shibuya 2001). VEGF is inducible by 
hypoxia-ischemia in vitro and in vivo and has been suggested 
as a likely candidate for the development of vasogenic brain 
edema (Schoch et al 2002). A 3–12-fold increase in VEGF 
gene expression has been reported in hypoxia (Ikeda et al 
1995; Levy et al 1995; Stein et al 1995).
Increased expression of VEGF has been reported in 
hypoxic brains (Schoch et al 2002; Kaur et al 2006), and 
astrocytes were identiﬁ  ed as the cells expressing VEGF 
(Kaur et al 2006). Upregulation of endogenous VEGF in 
astrocytes in hypoxia-ischemia is believed to interact with 
receptors for VEGF on the vessels and contribute to the dis-
ruption of blood-brain barrier (BBB) resulting in vascular 
leakage (Zhang et al 2000, 2002). Inhibition of VEGF is 
known to reduce the BBB permeability (Zhang et al 2000). 
Similar to the brain, increased production of VEGF and 
enhanced permeability of BRB was recently reported in 
the hypoxic retina and inhibition of VEGF production 
with melatonin reduced BRB permeability (Kaur et al 
2006, 2007).
In addition to its role in increasing vascular permeability, 
VEGF has also been described as an inﬂ  ammatory media-
tor which contributes to inﬂ  ammatory responses observed 
in cerebral ischemia (Croll et al 2004). The disruption of 
BBB by VEGF allows contact of normally sequestered 
central nervous system antigens with blood-borne immune 
mediators altering the immune privileged status of the brain 
(Proescholdt et al 1999). VEGF enhances the adhesion of 
leukocytes to vascular walls and increases intercellular cell 
adhesion molecule-1(ICAM-1) and vascular cell adhesion 
molecule-1 (VCAM-1) expression in the brain and retina 
(Melder et al 1996; Lu et al 1999; Min et al 2005). Overex-
posure of normal neural tissue to VEGF has been shown to 
enhance ICAM-1 and major histocompatibility complex class 
I and II expression (Proescholdt et al 2004). Many changes 
induced by diabetes such as ICAM-1 up-regulation, leukocyte 
adhesion and increased vascular permeability in the retina 
(Murata et al 1996; Amin et al 1997) have been reported to 
occur in nondiabetic retinas with intravitreous VEGF injec-
tions (Tolentino et al 1996; Lu et al 1999) supporting the 
role of VEGF in inﬂ  ammation. Suppression of inﬂ  ammation 
in retina after VEGF inhibition has been reported (Joussen 
et al 2002).
Intracellular edema has been reported to occur in isch-
emia through damage to the cell membrane ionic channels 
(Marmor 1999). Neuronal and/or glial swelling has been 
considered as a component of retinal edema. The neuronal 
cells have been reported to become edematous during isch-
emia and degenerate eventually in the post-ischemic period 
(Johnson 1974).
Hypoxia-ischemia and nitric oxide
NO is known to play an important role in the pathogenesis of 
neuronal injury during hypoxia-ischemia. NO is synthesized 
by the enzyme NOS from L-arginine. NOS exists in three 
isoforms: neuronal (nNOS) and endothelial (eNOS) which 
are constitutively expressed and inducible (iNOS). The 
activities of nNOS and eNOS are stimulated by increases in 
intracellular calcium whereas iNOS is calcium-independent, 
and NO generated from this isoform is known to mediate 
immune functions. Enhanced nNOS, eNOS, and iNOS 
expression has been reported in the retina in response to 
hypoxia (Kaur et al 2006).Clinical Ophthalmology 2008:2(4) 882
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NO has been described to have neuroprotective and 
neurotoxic roles (Iadeacola 1997). NO produced by the 
eNOS isoform is a protective response as it maintains retinal 
perfusion in hypoxic-ischemic conditions (Toda et al 2007). 
Vasodilation occurring after hypoxic-ischemic episodes is 
mediated by eNOS (Bolanos and Almeida 1999) leading 
to increased blood ﬂ  ow. Blood vessels in retina showed 
enhanced expression of eNOS following a hypoxic insult 
(Kaur et al 2006). However, it has been proposed that besides 
its beneﬁ  cial effects of producing vasodilatation and increas-
ing the blood ﬂ  ow, eNOS is also involved in VEGF-induced 
vascular hyperpermeability (Fukumura et al 2001).
All three types of NOS are produced in the retina in 
hypoxic-ischemic conditions (Kaur et al 2006) and glial 
cells have been suggested as the major cell types produc-
ing them (Kobayashi et al 2000; Kashiwagi et al 2003). In 
addition to glial cells, inﬁ  ltrating leukocytes may also be an 
important source of iNOS production. The RGCs were also 
reported to express iNOS and nNOS in the hypoxic retina 
(Kaur et al 2006). NO production from nNOS and iNOS 
contributes to cytotoxicity resulting in cell death and axonal 
damage. Other than generation of free radicals, a number of 
pathways such as N-methyl-D-aspartate (NMDA)-mediated 
intracellular Ca2+ inﬂ  ux and CREB-mediated transcription of 
apoptotic proteins such as Bax, Bad, and Bcl-xl are triggered 
by NO resulting in neuronal death (Mishra et al 2002, 2006; 
Zubrow et al 2002a, 2002b). Increased expression of Bax 
but not Bcl-2 in hypoxic cerebral tissue thus increasing the 
Bax/Bcl-2 ratio in favor of hypoxia-induced apoptosis has 
been reported (Mishra et al 2004). In retinal ischemia, RGCs 
death has been reported to be due to involvement of iNOS as 
it has been observed that iNOS-positive leukocytes enter the 
ganglion cell layer and surround the RGCs and cause their 
degeneration which could be prevented with an inhibitor of 
iNOS (Neufeld et al 2002).
NO induces the proapoptotic cascade in hypoxic neural 
tissues by increasing phosphorylation of Bcl-2 (Mishra et al 
2004). NO-mediated inactivation of MAPK phosphatases 
has been described as a potential mechanism of activation 
of ERK and JNK which leads to phosphorylation of the 
antiapoptotic protein Bcl-2 (Mishra et al 2004). The anti-
apoptotic potential of phosphorylated Bcl-2 is lost due to its 
inability to heterodimerize with the proapoptotic protein Bax, 
resulting in Bax-mediated activation of caspases and initia-
tion of apoptosis (St. Clair et al 1997, Haldar et al 1996; Hu 
et al 1998). Other mechanisms by which NO contributes to 
cytotoxicity may be peroxynitrite-mediated oxidative dam-
age, DNA damage, and energy failure (Beckman et al 1990; 
Nguyen et al 1992; Zhang et al 1994; Gross et al 1996). 
This observation is supported by recent studies which have 
suggested that peroxynitrite produced by iNOS is a highly 
reactive oxidant capable of inducing injury to a number of 
cell types (Li et al 2005).
Hypoxia-ischemia and excitotoxicity
Excitatory amino acids have been reported to play an impor-
tant role in the development of hypoxic-ischemic retinal 
injury. Glutamate, the excitatory neurotransmitter in the 
retina, is released by photoreceptors, bipolar cells and gan-
glion cells and mediates the transfer of visual signals from 
the retina to the brain (Massey 1990). However, augmented 
release of glutamate and its accumulation in extracellular 
spaces in hypoxic-ischemic conditions leading to activation 
of glutamate receptors has been implicated in hypoxic/isch-
emic neuronal death (Benveniste et al 1984; Lu et al 1993). 
Glutamate neurotoxicity is considered as the underlying 
problem in retinal neuropathies and neurodegenerative condi-
tions such as glaucoma (Dreyer 1998). Elevation of extracel-
lular glutamate concentration in the retina has been shown 
to mimic hypoxia induced changes in the electroretinogram 
(Ikeda et al 1995). Over-activation of glutamate receptors due 
to excess glutamate accumulation in the retina can contribute 
to retinal dysfunction (Dreyer 1998; Pang et al 1999).
Glutamate exerts its action through ionotropic (amino-
methyl-propionic-acid [AMPA], NMDA, and kainate glu-
tamate receptors) and metabotropic receptors (Brandstätter 
et al 1998; Gründer et al 2001). The metabotropic glutamate 
receptors (mGluRs) have been grouped into three main 
classes, group I (mGluR1 and 5), Group II (mGluR2, 3), 
and Group III (mGluR 4, 6, 7, 8) according to their amino 
acid sequence, pharmacological properties and transduction 
mechanisms (Conn and Pin 1997). RGCs express ionotropic 
receptors (Hartveit et al 1994; Brandstätter et al 1998) as well 
as mGluRs (Hartveit et al 1995). Glutamate receptor-mediated 
damage has been reported to occur in glaucoma, central, and 
branch retinal arterial and retinal vein occlusions resulting in 
loss of retinal ganglion cells (Sucher et al 1997).
Neurotoxic effects of glutamate are reported to occur 
predominantly through activation of ionotropic glutamate 
receptors (GluR) (Levy et al 1991). NMDA receptors are 
highly permeable to Ca2+ (MacDermott et al 1986; Hollmann 
et al 1991; Rörig and Grantyn 1993), their activation resulting 
in an increase in the intracellular calcium levels (Siliprandi 
et al 1992; Sucher et al 1990, 1991, 1997). Ca2+ overload 
has been reported to be a central event in neuronal death 
during ischemia (Nicotera and Orrenius 1998; Sattler and Clinical Ophthalmology 2008:2(4) 883
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Tymianski 2001). Many cellular functions such as regulation 
of enzymes require calcium. Abnormal higher concentrations 
of calcium lead to inappropriate activation of enzymes such 
as proteases, nucleases, and lipases which are harmful to the 
cellular constituents, generate free radicals as well as cause 
mitochondrial failure which results in energy depletion and 
further free radical production (Dugan et al 1995).
Depolarization of neuronal membranes due to energy 
failure results in Ca2+ inﬂ  ux through the voltage-dependent 
Ca2+ channels followed by Ca2+-dependent glutamate release 
(Katsura et al 1994) which further increases the extracel-
lular accumulation of glutamate. Activation of ionotropic 
glutamate receptors also results in inﬂ  ux of Na+ and Cl− ions, 
inducing osmotic swelling. Glutamate acting via NMDA 
receptors activates nNOS (Garthewaite and Garthewaite 
1991) and the production of NO (Kiss and Vizi 2001). 
Expression of ionotropic glutamate receptors (GluR2/3 and 
NMDA) has been reported to be upregulated in the RGCs in 
hypoxic-ischemic conditions (Kaur et al 2006).
Glutamate has also been reported to induce and exac-
erbate cell death by activating group I mGluRs (Allen et al 
2001; Hilton et al 2006). Neuronal excitation and excito-
toxicity is thought to be potentiated by Group I mGluRs 
(Buisson and Choi 1995; Pin and Duvoisin 1995; Buisson 
et al 1996), possibly through their interaction with NMDA 
receptors (Fitzjohn et al 1996; Bordi and Ugolini 1999). It 
has been reported that mGluR5 are coexpressed with, and 
functionally coupled to, NMDA receptors and that activation 
of mGluR5 enhances NMDA responses in neurons (Jia et al 
1998; Awad et al 2000; Salt and Binns 2000) contributing to 
neuronal death (Bruno et al 2000).
Glutamate is also known to be involved in the production 
of inﬂ  ammatory cytokines such as tumor necrosis factor-α 
(TNF-α) (De et al 2005). Glutamate-induced activation of 
AMPA and NMDA receptors has been shown to enhance the 
production of TNF-α (Noda et al 2000; Matute et al 2001) 
and interleukin-1 β (IL-1β) (Hagan et al 1996) signiﬁ  cantly. 
Co-operation between glutamate receptors and inﬂ  amma-
tory cytokines may be one of the mechanisms involved in 
cell damage.
Glutamate toxicity also results in glutathione depletion 
and oxidative stress (Ratan et al 1994). Glutathione is a major 
cellular antioxidant which protects the cells against oxidative 
stress (Meister and Anderson 1983; Mizui et al 1992; Bobyn 
et al 2002). Increase in intracellular reactive oxygen species 
(ROS) generation in response to glutathione depletion has 
been reported in several studies (Coyle and Puttfarcken 1993; 
Tan et al 1998).
Removal of excess glutamate from the extracellular space 
by glutamate transporters is crucial to terminate glutamate 
excitotoxicty. Glutamate transporters are responsible for the 
removal of glutamate from the extracellular ﬂ  uid in the retina 
(Danbolt 2001). It has been suggested that excess glutamate 
accumulation in the extracellular spaces may result from a 
failure of the glutamate transporters, such as GLAST, in the 
vicinity of  RGCs (Harada et al 2007). Glutamate transporters 
have been described as necessary to prevent excitotoxic 
retinal damage and to synthesize glutathione and their 
deﬁ  ciency has been reported to result in RGC degeneration 
(Harada et al 2007).
Hypoxia-ischemia 
and reactive oxygen species
Hypoxia-ischemia results in perturbation of the cellular pro-
oxidant-antioxidant balance by accumulation of ROS, known 
as oxidative stress, which has been implicated as an important 
mechanism of cytotoxicity. In vitro studies have shown that 
ROS generation in hypoxic-ischemic conditions in neurons 
occurs from three sources: mitochondria generating an initial 
burst of ROS followed by a second phase of ROS generation 
due to xanthine oxidase activation and a third phase of Ca2+-
dependent ROS generation (Abramov et al 2007).
ROS are known to cause lipid peroxidation, protein 
oxidation, and DNA oxidation, which contributes to neuro-
degeneration (Hall and Braugher 1989; Chan 1994, 1996). 
ROS can also stimulate ischemic cells to secrete inﬂ  amma-
tory cytokines and chemokines which induce cell damage 
and disruption of BBB (Wang et al 2007). ROS have been 
reported to be cytotoxic to RGCs (Tezel and Yang 2004) 
causing necrotic cell death by direct oxidative damage to 
cellular constituents and apoptotic death by participating 
in the signal transduction pathway for apoptosis (Kortuem 
et al 2000; Levkovitch-Verbin et al 2000; Lieven et al 2003, 
2006; Nguyen et al 2003).
NO, a free radical is produced by the endothelial cells and 
serves as a vasodilator (Garthwaite et al 1988; Lamas et al 
1992; Southam and Garthwaite 1993; Iadecola et al 1994). 
However, NO, as mentioned above, can also be neurotoxic 
causing neuronal death in hypoxic and excitotoxic insults 
(Dawson et al 1991; Moncada et al 1991; Boje and Arora 
1992; Lees 1993). It has been shown that NO can react with 
the superoxide anion (O2
-) to form peroxynitrite (OONO-) 
(Beckman et al 1990) which is neurotoxic (Lipton et al 1993). 
NO alone, even at high levels, has been reported as nontoxic 
to cortical neurons, but becomes neurotoxic after its reac-
tion with O2
- to form ONOO- (Lipton et al 1993). In vitro Clinical Ophthalmology 2008:2(4) 884
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studies have shown that formation of OONO- increases the 
VEGF-induced permeability of retinal microvascular endo-
thelial cells (Marumo et al 1999) and tissue damage through 
DNA damage, lipid peroxidation, and reduced cellular anti-
oxidant defenses (Salgo et al 1995; Salvemini et al 1998).
Hypoxia-ischemia and inﬂ  ammation
Hypoxia is known to regulate expression of many genes mod-
ulating inﬂ  ammation (Hedtjärn et al 2004). An acute inﬂ  am-
matory reaction, characterized by increased expression of 
proinﬂ  ammatory mediators (Szaﬂ  arski et al 1995; Bona et al 
1999), a rapid microglial/monocytic response (Ivako et al 
1996) and gliosis (Burtrum et al 1994), have been reported 
to be elicited in the brain by hypoxia-ischemia (Cowell et al 
2002). Many cell types including injured neurons have been 
reported as a major source of chemokines such as monocyte 
chemoattractant protein (MCP-1) (Ivako et al 1997) whereas 
expression of macrophage inﬂ  ammatory protein-α has been 
reported in monocytes and activated microglial cells (Cowell 
et al 2002) in hypoxic-ischemic brain injury. Chemokine 
receptors CCR2 and CCR5 have also been reported to be 
upregulated (Hedtjärn et al 2004). Chemokine expression 
may play a role in leukocyte recruitment and inﬁ  ltration 
in the inner retina, leading to RGC damage (Jo et al 2003). 
Leukocytes are known to play a central role in post-ischemic 
tissue damage (del-Zoppo et al 1991; Heinel et al 1994; 
Zhang et al 1994) by producing free radicals (Werns et al 
1985) and inﬂ  ammatory cytokines (Ghezzi et al 1991).
Hypoxia-ischemia is known to attract macro-
phages to hypoxic areas through expression of MCP-1. 
The hypoxia-activated macrophages and microglia, the 
immune effector cells in the retina, release TNF-α which has 
been reported as a triggering factor to activate production of 
interleukin-8 (IL-8), VEGF, or MCP-1 in retinal vascular 
cells and/or glial cells adjacent to microvessels (Yoshida et al 
2004). Expression of TNF-α and cyclooxygenase-2 (COX-2) 
was reported recently in the ischemic retina (Zheng et al 
2007). Several inﬂ  ammatory molecules including ICAM-1, 
TNF-α, IL-1β, iNOS, and COX-2 released by activated 
inﬂ  ammatory cells and glial elements play a major role in 
degeneration of retinal capillaries (Joussen et al 2004; Zheng 
et al 2007) and subsequently the RGCs.
Expression of adhesion molecules, ICAM-1 and 
VCAM-1, on the endothelial cells facilitating leukocyte 
adhesion and inﬁ  ltration into the areas of damage has been 
reported to be induced by TNF-α (Wong and Dorovini, 
1992; Hess et al 1994; McHale et al 1999). In vitro studies 
have shown that IL-1β and TNF-α induce ICAM-1 expres-
sion in endothelial cells (Feuerstein et al 1998). ICAM-1 is 
important for establishing adhesion of leukocytes before their 
movement across the endothelium into the tissue (Wang et al 
1994).
IL-1β and TNF-α may also be involved in transcriptional 
activation of the iNOS gene (Lopez-Figueroa et al 2000; 
Kadhim et al 2006). Endothelial cells of brain microvessels 
are known to express iNOS and produce large amounts of 
NO under inﬂ  ammatory conditions as IL-1β has an important 
role in iNOS expression and NO generation (Betz et al 1996; 
Bonmann et al 1997). Induction of IL-1 β gene expression in 
the vascular wall, accompanied by perivascular induction of 
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Figure 1 Potential mediators of RGC death in retinal hypoxia-ischemia.Clinical Ophthalmology 2008:2(4) 885
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iNOS mRNA was observed in the rat brain during systemic 
inﬂ  ammation (Wong et al 1996). Increased release of IL-1β 
and TNF-α in the retina in hypoxic-ischemic conditions may 
have a similar action.
Conclusion
Retinal hypoxia results in increased release VEGF, NO, 
glutamate, inﬂ  ammatory cytokines and ROS (Figure 1). 
These processes result in RGC loss through various 
mechanisms such as disruption of BRB, excitotoxicity and 
increased accumulation of intracellular Ca2+. Understanding 
of the processes outlined in this review may provide new 
strategies to minimize RGC loss and possibly counteract 
or prevent it.
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